Dissemination of clinical practice guidelines for hepatocellular carcinoma among Japanese hepatologists and liver surgeons

Norihiro Kokudo, Masatoshi Makuuchi, Takeo Nakayama, Shigeki Arii, Masao Omata, Masatoshi Kudo, Masamichi Kojiro, Michiie Sakamoto, Ken Ichi Takayasu, Norio Hayashi, Morito Monden

Research output: Contribution to journalArticle

Abstract

"Clinical practice guidelines for hepatocellular carcinoma (HCC)," the first evidence-based guidelines for the treatment of HCC in Japan (the J-HCC Guidelines) have been compiled and English translation has just been completed (http://www.jsh.or.jp/). In March 2006, approximately a year after publication of the J-HCC Guideline Book, a questionnaire survey was conducted to investigate the level of awareness and influence of the guidelines among 2,279 members of the Liver Cancer Study Group of Japan. Of the 843 responders (37.0%), the J-HCC Guidelines have been acknowledged by 72% and 78.8% considered the guidelines useful for their daily practice. Algorithm for the treatment was most commonly used. After the introduction of the guidelines, only 20.8% of the responders changed their practice pattern; 40.3% did not change and were convinced that their choice of treatment was similar to the recommendations in the guidelines. In conclusion, one year after their publication, the J-HCC Guidelines have become well disseminated among specialists for HCC in Japan. As expected, these guidelines have begun to be applied at every level of clinical decision-making for HCC.

Original languageEnglish
Pages (from-to)562-570
Number of pages9
JournalActa Hepatologica Japonica
Volume48
Issue number11
DOIs
Publication statusPublished - 2007

Fingerprint

Practice Guidelines
Hepatocellular Carcinoma
Guidelines
Liver
Japan
Publications
Gastroenterologists
Surgeons
Liver Neoplasms
Therapeutics

Keywords

  • Clinical practice guidelines
  • Evidence-based medicine
  • Hepatocellular carcinoma

ASJC Scopus subject areas

  • Hepatology

Cite this

Dissemination of clinical practice guidelines for hepatocellular carcinoma among Japanese hepatologists and liver surgeons. / Kokudo, Norihiro; Makuuchi, Masatoshi; Nakayama, Takeo; Arii, Shigeki; Omata, Masao; Kudo, Masatoshi; Kojiro, Masamichi; Sakamoto, Michiie; Takayasu, Ken Ichi; Hayashi, Norio; Monden, Morito.

In: Acta Hepatologica Japonica, Vol. 48, No. 11, 2007, p. 562-570.

Research output: Contribution to journalArticle

Kokudo, N, Makuuchi, M, Nakayama, T, Arii, S, Omata, M, Kudo, M, Kojiro, M, Sakamoto, M, Takayasu, KI, Hayashi, N & Monden, M 2007, 'Dissemination of clinical practice guidelines for hepatocellular carcinoma among Japanese hepatologists and liver surgeons', Acta Hepatologica Japonica, vol. 48, no. 11, pp. 562-570. https://doi.org/10.2957/kanzo.48.562
Kokudo, Norihiro ; Makuuchi, Masatoshi ; Nakayama, Takeo ; Arii, Shigeki ; Omata, Masao ; Kudo, Masatoshi ; Kojiro, Masamichi ; Sakamoto, Michiie ; Takayasu, Ken Ichi ; Hayashi, Norio ; Monden, Morito. / Dissemination of clinical practice guidelines for hepatocellular carcinoma among Japanese hepatologists and liver surgeons. In: Acta Hepatologica Japonica. 2007 ; Vol. 48, No. 11. pp. 562-570.
@article{4c7afb7d55ab436fb2930d5666ff59a9,
title = "Dissemination of clinical practice guidelines for hepatocellular carcinoma among Japanese hepatologists and liver surgeons",
abstract = "{"}Clinical practice guidelines for hepatocellular carcinoma (HCC),{"} the first evidence-based guidelines for the treatment of HCC in Japan (the J-HCC Guidelines) have been compiled and English translation has just been completed (http://www.jsh.or.jp/). In March 2006, approximately a year after publication of the J-HCC Guideline Book, a questionnaire survey was conducted to investigate the level of awareness and influence of the guidelines among 2,279 members of the Liver Cancer Study Group of Japan. Of the 843 responders (37.0{\%}), the J-HCC Guidelines have been acknowledged by 72{\%} and 78.8{\%} considered the guidelines useful for their daily practice. Algorithm for the treatment was most commonly used. After the introduction of the guidelines, only 20.8{\%} of the responders changed their practice pattern; 40.3{\%} did not change and were convinced that their choice of treatment was similar to the recommendations in the guidelines. In conclusion, one year after their publication, the J-HCC Guidelines have become well disseminated among specialists for HCC in Japan. As expected, these guidelines have begun to be applied at every level of clinical decision-making for HCC.",
keywords = "Clinical practice guidelines, Evidence-based medicine, Hepatocellular carcinoma",
author = "Norihiro Kokudo and Masatoshi Makuuchi and Takeo Nakayama and Shigeki Arii and Masao Omata and Masatoshi Kudo and Masamichi Kojiro and Michiie Sakamoto and Takayasu, {Ken Ichi} and Norio Hayashi and Morito Monden",
year = "2007",
doi = "10.2957/kanzo.48.562",
language = "English",
volume = "48",
pages = "562--570",
journal = "Acta Hepatologica Japonica",
issn = "0451-4203",
publisher = "Japan Society of Hepatology",
number = "11",

}

TY - JOUR

T1 - Dissemination of clinical practice guidelines for hepatocellular carcinoma among Japanese hepatologists and liver surgeons

AU - Kokudo, Norihiro

AU - Makuuchi, Masatoshi

AU - Nakayama, Takeo

AU - Arii, Shigeki

AU - Omata, Masao

AU - Kudo, Masatoshi

AU - Kojiro, Masamichi

AU - Sakamoto, Michiie

AU - Takayasu, Ken Ichi

AU - Hayashi, Norio

AU - Monden, Morito

PY - 2007

Y1 - 2007

N2 - "Clinical practice guidelines for hepatocellular carcinoma (HCC)," the first evidence-based guidelines for the treatment of HCC in Japan (the J-HCC Guidelines) have been compiled and English translation has just been completed (http://www.jsh.or.jp/). In March 2006, approximately a year after publication of the J-HCC Guideline Book, a questionnaire survey was conducted to investigate the level of awareness and influence of the guidelines among 2,279 members of the Liver Cancer Study Group of Japan. Of the 843 responders (37.0%), the J-HCC Guidelines have been acknowledged by 72% and 78.8% considered the guidelines useful for their daily practice. Algorithm for the treatment was most commonly used. After the introduction of the guidelines, only 20.8% of the responders changed their practice pattern; 40.3% did not change and were convinced that their choice of treatment was similar to the recommendations in the guidelines. In conclusion, one year after their publication, the J-HCC Guidelines have become well disseminated among specialists for HCC in Japan. As expected, these guidelines have begun to be applied at every level of clinical decision-making for HCC.

AB - "Clinical practice guidelines for hepatocellular carcinoma (HCC)," the first evidence-based guidelines for the treatment of HCC in Japan (the J-HCC Guidelines) have been compiled and English translation has just been completed (http://www.jsh.or.jp/). In March 2006, approximately a year after publication of the J-HCC Guideline Book, a questionnaire survey was conducted to investigate the level of awareness and influence of the guidelines among 2,279 members of the Liver Cancer Study Group of Japan. Of the 843 responders (37.0%), the J-HCC Guidelines have been acknowledged by 72% and 78.8% considered the guidelines useful for their daily practice. Algorithm for the treatment was most commonly used. After the introduction of the guidelines, only 20.8% of the responders changed their practice pattern; 40.3% did not change and were convinced that their choice of treatment was similar to the recommendations in the guidelines. In conclusion, one year after their publication, the J-HCC Guidelines have become well disseminated among specialists for HCC in Japan. As expected, these guidelines have begun to be applied at every level of clinical decision-making for HCC.

KW - Clinical practice guidelines

KW - Evidence-based medicine

KW - Hepatocellular carcinoma

UR - http://www.scopus.com/inward/record.url?scp=53849134188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53849134188&partnerID=8YFLogxK

U2 - 10.2957/kanzo.48.562

DO - 10.2957/kanzo.48.562

M3 - Article

AN - SCOPUS:53849134188

VL - 48

SP - 562

EP - 570

JO - Acta Hepatologica Japonica

JF - Acta Hepatologica Japonica

SN - 0451-4203

IS - 11

ER -